Jaguar Health (JAGX) Competitors $0.93 +0.05 (+6.00%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends JAGX vs. ACHL, CLNN, DTIL, LEXX, VYNE, ATNM, OCX, LTRN, ELEV, and LUMOShould you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include Achilles Therapeutics (ACHL), Clene (CLNN), Precision BioSciences (DTIL), Lexaria Bioscience (LEXX), VYNE Therapeutics (VYNE), Actinium Pharmaceuticals (ATNM), OncoCyte (OCX), Lantern Pharma (LTRN), Elevation Oncology (ELEV), and Lumos Pharma (LUMO). These companies are all part of the "pharmaceutical products" industry. Jaguar Health vs. Achilles Therapeutics Clene Precision BioSciences Lexaria Bioscience VYNE Therapeutics Actinium Pharmaceuticals OncoCyte Lantern Pharma Elevation Oncology Lumos Pharma Achilles Therapeutics (NASDAQ:ACHL) and Jaguar Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment, community ranking and valuation. Does the media prefer ACHL or JAGX? In the previous week, Jaguar Health had 1 more articles in the media than Achilles Therapeutics. MarketBeat recorded 1 mentions for Jaguar Health and 0 mentions for Achilles Therapeutics. Jaguar Health's average media sentiment score of 0.16 beat Achilles Therapeutics' score of 0.00 indicating that Jaguar Health is being referred to more favorably in the news media. Company Overall Sentiment Achilles Therapeutics Neutral Jaguar Health Neutral Which has preferable valuation & earnings, ACHL or JAGX? Jaguar Health has higher revenue and earnings than Achilles Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAchilles TherapeuticsN/AN/A-$69.67M-$1.65-0.59Jaguar Health$10.48M1.04-$41.30MN/AN/A Do analysts recommend ACHL or JAGX? Achilles Therapeutics currently has a consensus price target of $4.00, indicating a potential upside of 308.16%. Given Achilles Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Achilles Therapeutics is more favorable than Jaguar Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Achilles Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Jaguar Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, ACHL or JAGX? Achilles Therapeutics has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Jaguar Health has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Does the MarketBeat Community believe in ACHL or JAGX? Jaguar Health received 1818 more outperform votes than Achilles Therapeutics when rated by MarketBeat users. Likewise, 88.73% of users gave Jaguar Health an outperform vote while only 54.84% of users gave Achilles Therapeutics an outperform vote. CompanyUnderperformOutperformAchilles TherapeuticsOutperform Votes1754.84% Underperform Votes1445.16% Jaguar HealthOutperform Votes183588.73% Underperform Votes23311.27% Do institutionals & insiders have more ownership in ACHL or JAGX? 56.4% of Achilles Therapeutics shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Health shares are owned by institutional investors. 5.4% of Achilles Therapeutics shares are owned by insiders. Comparatively, 0.0% of Jaguar Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is ACHL or JAGX more profitable? Achilles Therapeutics has a net margin of 0.00% compared to Jaguar Health's net margin of -360.13%. Achilles Therapeutics' return on equity of -54.45% beat Jaguar Health's return on equity.Company Net Margins Return on Equity Return on Assets Achilles TherapeuticsN/A -54.45% -47.68% Jaguar Health -360.13%-326.62%-67.02% SummaryAchilles Therapeutics beats Jaguar Health on 9 of the 15 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get Jaguar Health News Delivered to You Automatically Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JAGX vs. The Competition Export to ExcelMetricJaguar HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.92M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E RatioN/A10.5589.7417.16Price / Sales1.04196.061,117.09117.04Price / CashN/A57.1643.1037.86Price / Book0.235.094.784.78Net Income-$41.30M$151.83M$120.31M$225.60M7 Day Performance-4.52%-2.14%-1.92%-1.23%1 Month Performance-11.01%-4.56%13.65%0.46%1 Year Performance-90.74%8.87%28.34%15.24% Jaguar Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JAGXJaguar Health0.2597 of 5 stars$0.93+6.0%N/A-89.9%$10.92M$10.48M0.0050News CoverageGap UpACHLAchilles Therapeutics2.9925 of 5 stars$0.99-0.2%$4.00+304.9%+18.0%$40.60MN/A-0.60250CLNNClene3.73 of 5 stars$4.75-4.0%$55.25+1,063.2%-30.2%$39.71M$650,000.00-0.94100Analyst ForecastNews CoverageDTILPrecision BioSciences4.471 of 5 stars$5.08-6.6%$39.50+677.6%-55.5%$38.97M$75.10M90.67200Positive NewsLEXXLexaria Bioscience3.1487 of 5 stars$2.22-0.9%$11.00+395.5%+66.4%$38.75M$464,278.00-4.777VYNEVYNE Therapeutics2.6593 of 5 stars$2.60+1.6%$6.88+164.4%-1.6%$38.35M$493,000.00-2.9830News CoverageATNMActinium Pharmaceuticals1.2441 of 5 stars$1.22-0.8%$7.40+506.6%N/A$38.06M$81,000.00-0.8849OCXOncoCyte3.2596 of 5 stars$2.26-2.6%$4.42+95.4%-23.2%$38.04M$1.50M0.00120Analyst ForecastGap DownLTRNLantern PharmaN/A$3.52+2.0%N/A-24.0%$37.96MN/A-1.9420Gap DownELEVElevation Oncology1.9868 of 5 stars$0.64+0.6%$7.20+1,025.0%+30.0%$37.84MN/A-0.7840Analyst ForecastLUMOLumos Pharma3.0946 of 5 stars$4.34flat$8.63+98.7%+45.6%$37.54M$2.21M-1.0130High Trading Volume Related Companies and Tools Related Companies ACHL Alternatives CLNN Alternatives DTIL Alternatives LEXX Alternatives VYNE Alternatives ATNM Alternatives OCX Alternatives LTRN Alternatives ELEV Alternatives LUMO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:JAGX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jaguar Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JAGX Stock Alerts